Top 10 Companies in the (R)-3-Chloro-styreneoxide (CAS 62600-71-9) Market (2026): Market Leaders Powering Global Chiral Chemistry

MARKET INSIGHTS

The global (R)-3-Chloro-styreneoxide (CAS 62600-71-9) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.7 million by 2034, exhibiting a CAGR of 6.5% during the forecast period.

(R)-3-Chloro-styreneoxide, identified by CAS number 62600-71-9, is a chiral epoxide compound belonging to the class of aromatic styrene oxides. It is characterized by a three-membered epoxide ring attached to a chlorine-substituted phenyl group, with the (R)-configuration denoting its specific stereochemical orientation. This compound serves as a valuable chiral building block and synthetic intermediate in the production of pharmaceuticals, agrochemicals, and fine chemicals, where enantiopurity is a critical requirement.

The market is witnessing steady growth driven by the rising demand for enantiomerically pure intermediates in asymmetric synthesis and the expanding pharmaceutical pipeline that relies on chiral chemistry. Furthermore, growing investments in green chemistry and biocatalytic production methods are enhancing the cost-efficiency and scalability of chiral epoxide manufacturing. Key suppliers and specialty chemical manufacturers across North America, Europe, and Asia-Pacific continue to expand their portfolios to meet evolving industry requirements.

(R)-3-Chloro-styreneoxide (CAS 62600-71-9) Market – View in Detailed Research Report

🔟 1. Finetech Industry Limited

Headquarters: Shanghai, China
Key Offering: GMP‑compliant chiral epoxide synthesis, high‑ee (R)-3‑Chloro‑styreneoxide for pharmaceutical intermediates

Finetech Industry Limited has established itself as a leading custom manufacturer of chiral epoxides, leveraging advanced Jacobsen hydrolytic kinetic resolution and biocatalytic processes. The company’s state‑of‑the‑art facilities ensure >99% enantiomeric excess, meeting stringent regulatory requirements for drug development.

Sustainability Initiatives:

• Implementation of renewable energy sources in production lines
• Zero‑waste epoxide synthesis through process intensification
• Partnerships with pharma clients for green chemistry R&D

9️⃣ 2. Hairui Chemical Co., Ltd.

Headquarters: Nanjing, China
Key Offering: High‑purity (R)-3‑Chloro‑styreneoxide for fine chemical and agrochemical applications

Hairui Chemical Co., Ltd. specializes in scalable resolution of chlorostyrene derivatives, providing both laboratory and industrial grades. Their process achieves >98% ee with reduced solvent usage, aligning with global sustainability goals.

Sustainability Initiatives:

• Adoption of greener solvents (e.g., ethanol, ethyl acetate) in epoxide production
• Carbon‑neutral manufacturing through renewable electricity procurement
• Collaboration with research institutions for enzymatic resolution development

8️⃣ 3. Capot Chemical Co., Ltd.

Headquarters: Guangzhou, China
Key Offering: Custom chiral epoxide synthesis with flexible scale for API manufacturing

Capot Chemical Co., Ltd. focuses on rapid turnaround for contract manufacturing organizations (CMOs), offering high‑purity (R)-3‑Chloro‑styreneoxide with customizable batch sizes and rapid delivery schedules.

Sustainability Initiatives:

• Implementation of water‑recycling systems in epoxide synthesis
• Energy‑efficient reactor designs reducing CO₂ footprint by 20%
• Participation in industry green chemistry forums

7️⃣ 4. BOC Sciences

Headquarters: San Francisco, USA
Key Offering: Advanced chiral resolution technologies for pharmaceutical intermediates

BOC Sciences brings cutting‑edge asymmetric catalysis to the US market, providing (R)-3‑Chloro‑styreneoxide with >99% ee and rapid scale‑up capabilities for late‑stage functionalization of drug candidates.

Sustainability Initiatives:

• Investments in biocatalytic epoxidation platforms
• Reduction of hazardous waste streams through solvent‑free processes
• Collaboration with FDA for green chemistry compliance pathways

6️⃣ 5. Shanghai Trustin Chemical Co., Ltd.

Headquarters: Shanghai, China
Key Offering: High‑purity (R)-3‑Chloro‑styreneoxide for agrochemical synthesis

Shanghai Trustin Chemical Co., Ltd. supplies both laboratory and industrial grades, with a focus on agrochemical intermediates that require strict optical purity for efficacy and regulatory approval.

Sustainability Initiatives:

• Use of biodegradable polymeric supports in catalytic processes
• Implementation of closed‑loop solvent recovery systems
• Engagement in regional sustainability certification programs

5️⃣ 6. Biosynth Carbosynth

Headquarters: Basel, Switzerland
Key Offering: Biocatalytic synthesis of (R)-3‑Chloro‑styreneoxide for fine chemicals

Biosynth Carbosynth specializes in enzyme‑mediated resolution, offering high‑yield, low‑energy processes that deliver >99% ee (R)-3‑Chloro‑styreneoxide suitable for pharmaceutical and specialty chemical applications.

Sustainability Initiatives:

• Adoption of renewable enzyme production platforms
• Carbon‑neutral manufacturing through solar‑powered facilities
• Partnerships with EU green chemistry initiatives

4️⃣ 7. Hangzhou Dayangchem Co. Ltd.

Headquarters: Hangzhou, China
Key Offering: Custom chiral epoxide solutions for pharma and agrochemical sectors

Hangzhou Dayangchem Co. Ltd. provides tailored synthesis routes with rapid scale‑up, ensuring high‑purity (R)-3‑Chloro‑styreneoxide for complex drug candidates and agrochemical intermediates.

Sustainability Initiatives:

• Implementation of green chemistry guidelines in all processes
• Reduction of hazardous waste by 30% through process optimization
• Collaboration with universities for sustainable catalysis research

3️⃣ 8. Enamine LLC

Headquarters: Kyiv, Ukraine
Key Offering: Library synthesis of chiral epoxides for drug discovery

Enamine LLC focuses on rapid synthesis of chiral epoxides for medicinal chemistry libraries, providing (R)-3‑Chloro‑styreneoxide with >98% ee in small‑scale, high‑throughput formats.

Sustainability Initiatives:

• Use of biocatalysts for low‑energy epoxide production
• Waste‑minimization through integrated solvent recycling
• Participation in global green chemistry networks

2️⃣ 9. Apollo Scientific Ltd.

Headquarters: London, United Kingdom
Key Offering: High‑purity (R)-3‑Chloro‑styreneoxide for specialty chemical research

Apollo Scientific Ltd. supplies both laboratory and industrial grades, supporting research institutions and pharma companies with strict enantiomeric excess requirements.

Sustainability Initiatives:

• Adoption of green solvents and energy‑efficient reactors
• Carbon‑neutral production through renewable energy sourcing
• Collaboration with UK regulatory bodies on green chemistry standards

1️⃣ 10. PharmaBlock Sciences

Headquarters: Shenzhen, China
Key Offering: Custom chiral epoxide solutions for large‑scale pharmaceutical production

PharmaBlock Sciences offers scalable synthesis of (R)-3‑Chloro‑styreneoxide with >99% ee, supporting both API and active ingredient manufacturing for global pharma players.

Sustainability Initiatives:

• Implementation of renewable energy in production facilities
• Zero‑waste epoxide manufacturing through process intensification
• Partnerships with global pharma for green chemistry R&D

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/307581/chlorostyreneoxide-market

Get Full Report Here: https://www.24chemicalresearch.com/reports/307581/chlorostyreneoxide-market

Market Outlook 2026‑2034

The (R)-3‑Chloro‑styreneoxide market is projected to grow at a CAGR of 6.5% from USD 30.1 million in 2026 to USD 52.7 million by 2034. Growth is driven by expanding pharmaceutical pipelines that demand enantiomerically pure intermediates, increasing adoption of biocatalytic and asymmetric synthesis technologies, and a global push toward sustainable chemical manufacturing.

Emerging Trends & Future Outlook

Key trends shaping the future of the (R)-3‑Chloro‑styreneoxide market include:

• Advancements in biocatalytic production, reducing cost by up to 30% and lowering energy consumption.
• Growing emphasis on green chemistry, with 40% of new production lines incorporating asymmetric epoxidation and enzyme‑based processes.
• Expansion of the Asia‑Pacific manufacturing base, particularly in China and India, driven by government incentives and cost advantages.
• Increasing collaboration between contract development and manufacturing organizations (CDMOs) and pharmaceutical giants to accelerate time‑to‑market for chiral drug candidates.
• Rising demand for high‑purity (R)-3‑Chloro‑styreneoxide in agrochemical synthesis, driven by low‑dose, high‑efficacy formulations and sustainability regulations.

By 2030, sustainability initiatives are expected to double market penetration in green chemistry, while pricing is projected to stabilize around USD 1,200‑1,500 per kg for standard grades, with premium high‑ee grades commanding higher margins.